Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912498632> ?p ?o ?g. }
- W2912498632 endingPage "607" @default.
- W2912498632 startingPage "597" @default.
- W2912498632 abstract "Caffeine is used as an adjuvant in analgesic combinations to enhance their efficacy. The present study aimed to determine the effect of caffeine on the pharmacokinetics of acetylsalicylic acid (ASA) and paracetamol when used as a fixed-dose ASA/paracetamol/caffeine combination. In this single-centre, two-way, cross-over phase I study, volunteers fasted overnight (≥ 12 h) and randomly received single oral doses of 250 mg ASA/200 mg paracetamol (reference) or 250 mg ASA/200 mg paracetamol/50 mg caffeine (test). Blood samples were collected before and up to 24 h after dosing. The primary end points were the area under the concentration-time curve from zero to infinity (AUC0–∞) and maximum plasma concentration (Cmax) for ASA, salicylic acid (SA) and paracetamol from the two combinations. The main secondary end points were AUC0–∞ and Cmax of caffeine and time to reach Cmax (tmax) of all drugs. Eighteen healthy male volunteers (32.5 ± 10.5 years) participated in the study. The geometric means of Cmax for ASA, SA and paracetamol were similar in the test (3.71, 15.8 and 2.42 µg/ml, respectively) and reference groups (3.89, 15.8, 2.42 µg/ml, respectively). The geometric mean of AUC0–∞ for ASA, SA and paracetamol from the test combination was 2.86, 60.5 and 7.68 µg h/ml, respectively, and that for the reference was 2.96, 59.1 and 7.77 µg h/ml, respectively. The medians of tmax for ASA, SA and paracetamol were similar between the two groups. The point estimates for the ratios of AUC0–∞ and Cmax for test versus reference regarding ASA, SA and paracetamol were within the predefined equivalence limits. The two treatments were well tolerated. Caffeine did not affect the pharmacokinetics of ASA and paracetamol when used as an adjuvant in ASA/paracetamol fixed-dose combination under fasting conditions, suggesting that caffeine enhances the analgesic efficacy of these drugs by pharmacodynamic rather than pharmacokinetic interactions. Sanofi-Aventis Deutschland GmbH." @default.
- W2912498632 created "2019-02-21" @default.
- W2912498632 creator A5023818933 @default.
- W2912498632 creator A5046637108 @default.
- W2912498632 date "2019-02-13" @default.
- W2912498632 modified "2023-10-15" @default.
- W2912498632 title "Effect of Caffeine on the Bioavailability and Pharmacokinetics of an Acetylsalicylic Acid-Paracetamol Combination: Results of a Phase I Study" @default.
- W2912498632 cites W170700970 @default.
- W2912498632 cites W177732556 @default.
- W2912498632 cites W1826960795 @default.
- W2912498632 cites W1977960132 @default.
- W2912498632 cites W1979170119 @default.
- W2912498632 cites W1990564216 @default.
- W2912498632 cites W1991388994 @default.
- W2912498632 cites W1991519612 @default.
- W2912498632 cites W1991600909 @default.
- W2912498632 cites W2002570169 @default.
- W2912498632 cites W2035192529 @default.
- W2912498632 cites W2073000525 @default.
- W2912498632 cites W2083679048 @default.
- W2912498632 cites W2087869961 @default.
- W2912498632 cites W2100000114 @default.
- W2912498632 cites W2165141461 @default.
- W2912498632 cites W2166473230 @default.
- W2912498632 cites W2166500361 @default.
- W2912498632 cites W2206690359 @default.
- W2912498632 cites W2425853908 @default.
- W2912498632 cites W2596148163 @default.
- W2912498632 cites W2745691773 @default.
- W2912498632 cites W2924501792 @default.
- W2912498632 cites W4229977739 @default.
- W2912498632 cites W4245945403 @default.
- W2912498632 cites W59490286 @default.
- W2912498632 doi "https://doi.org/10.1007/s12325-019-0891-5" @default.
- W2912498632 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6824350" @default.
- W2912498632 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30758744" @default.
- W2912498632 hasPublicationYear "2019" @default.
- W2912498632 type Work @default.
- W2912498632 sameAs 2912498632 @default.
- W2912498632 citedByCount "13" @default.
- W2912498632 countsByYear W29124986322020 @default.
- W2912498632 countsByYear W29124986322021 @default.
- W2912498632 countsByYear W29124986322022 @default.
- W2912498632 countsByYear W29124986322023 @default.
- W2912498632 crossrefType "journal-article" @default.
- W2912498632 hasAuthorship W2912498632A5023818933 @default.
- W2912498632 hasAuthorship W2912498632A5046637108 @default.
- W2912498632 hasBestOaLocation W29124986321 @default.
- W2912498632 hasConcept C112705442 @default.
- W2912498632 hasConcept C126322002 @default.
- W2912498632 hasConcept C142724271 @default.
- W2912498632 hasConcept C181389837 @default.
- W2912498632 hasConcept C185592680 @default.
- W2912498632 hasConcept C204787440 @default.
- W2912498632 hasConcept C22979827 @default.
- W2912498632 hasConcept C27081682 @default.
- W2912498632 hasConcept C2778221352 @default.
- W2912498632 hasConcept C2778500429 @default.
- W2912498632 hasConcept C2778722691 @default.
- W2912498632 hasConcept C2779252780 @default.
- W2912498632 hasConcept C2780820201 @default.
- W2912498632 hasConcept C55493867 @default.
- W2912498632 hasConcept C71924100 @default.
- W2912498632 hasConcept C87813604 @default.
- W2912498632 hasConcept C98274493 @default.
- W2912498632 hasConceptScore W2912498632C112705442 @default.
- W2912498632 hasConceptScore W2912498632C126322002 @default.
- W2912498632 hasConceptScore W2912498632C142724271 @default.
- W2912498632 hasConceptScore W2912498632C181389837 @default.
- W2912498632 hasConceptScore W2912498632C185592680 @default.
- W2912498632 hasConceptScore W2912498632C204787440 @default.
- W2912498632 hasConceptScore W2912498632C22979827 @default.
- W2912498632 hasConceptScore W2912498632C27081682 @default.
- W2912498632 hasConceptScore W2912498632C2778221352 @default.
- W2912498632 hasConceptScore W2912498632C2778500429 @default.
- W2912498632 hasConceptScore W2912498632C2778722691 @default.
- W2912498632 hasConceptScore W2912498632C2779252780 @default.
- W2912498632 hasConceptScore W2912498632C2780820201 @default.
- W2912498632 hasConceptScore W2912498632C55493867 @default.
- W2912498632 hasConceptScore W2912498632C71924100 @default.
- W2912498632 hasConceptScore W2912498632C87813604 @default.
- W2912498632 hasConceptScore W2912498632C98274493 @default.
- W2912498632 hasFunder F4320307781 @default.
- W2912498632 hasIssue "3" @default.
- W2912498632 hasLocation W29124986321 @default.
- W2912498632 hasLocation W29124986322 @default.
- W2912498632 hasLocation W29124986323 @default.
- W2912498632 hasLocation W29124986324 @default.
- W2912498632 hasOpenAccess W2912498632 @default.
- W2912498632 hasPrimaryLocation W29124986321 @default.
- W2912498632 hasRelatedWork W1981835538 @default.
- W2912498632 hasRelatedWork W2072642986 @default.
- W2912498632 hasRelatedWork W2106538704 @default.
- W2912498632 hasRelatedWork W2121556602 @default.
- W2912498632 hasRelatedWork W2319508947 @default.
- W2912498632 hasRelatedWork W2357181023 @default.
- W2912498632 hasRelatedWork W2614264529 @default.
- W2912498632 hasRelatedWork W26450692 @default.